APA

Staveley-O'Carroll K., Schell T. D., Jimenez M., Mylin L. M., Tevethia M. J., Schoenberger S. P. & Tevethia S. S. (20031023). In vivo ligation of CD40 enhances priming against the endogenous tumor antigen and promotes CD8+ T cell effector function in SV40 T antigen transgenic mice. : Journal of immunology (Baltimore, Md. : 1950).

Chicago

Staveley-O'Carroll Kevin, Schell Todd D, Jimenez Marcela, Mylin Lawrence M, Tevethia M Judith, Schoenberger Stephen P and Tevethia Satvir S. 20031023. In vivo ligation of CD40 enhances priming against the endogenous tumor antigen and promotes CD8+ T cell effector function in SV40 T antigen transgenic mice. : Journal of immunology (Baltimore, Md. : 1950).

Harvard

Staveley-O'Carroll K., Schell T. D., Jimenez M., Mylin L. M., Tevethia M. J., Schoenberger S. P. and Tevethia S. S. (20031023). In vivo ligation of CD40 enhances priming against the endogenous tumor antigen and promotes CD8+ T cell effector function in SV40 T antigen transgenic mice. : Journal of immunology (Baltimore, Md. : 1950).

MLA

Staveley-O'Carroll Kevin, Schell Todd D, Jimenez Marcela, Mylin Lawrence M, Tevethia M Judith, Schoenberger Stephen P and Tevethia Satvir S. In vivo ligation of CD40 enhances priming against the endogenous tumor antigen and promotes CD8+ T cell effector function in SV40 T antigen transgenic mice. : Journal of immunology (Baltimore, Md. : 1950). 20031023.